BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Abstract Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76

Documents similaires